• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多学科团队在晚期帕金森病管理中的作用和结构,重点关注左旋多巴-卡比多巴肠凝胶的使用

The role and structure of the multidisciplinary team in the management of advanced Parkinson's disease with a focus on the use of levodopa-carbidopa intestinal gel.

作者信息

Pedersen Stephen W, Suedmeyer Martin, Liu Louis W C, Domagk Dirk, Forbes Alison, Bergmann Lars, Onuk Koray, Yegin Ashley, van Laar Teus

机构信息

Department of Neurology, Glostrup Hospital, University of Copenhagen, Glostrup, Copenhagen, Denmark.

Department of Neurology, University of Düesseldorf, Düesseldorf, Germany.

出版信息

J Multidiscip Healthc. 2017 Jan 4;10:13-27. doi: 10.2147/JMDH.S111369. eCollection 2017.

DOI:10.2147/JMDH.S111369
PMID:28115853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5221801/
Abstract

A multidisciplinary team (MDT) approach is increasingly recommended in Parkinson's disease (PD) treatment guidelines, but no standard of care exists for such an approach, and the guidelines do not provide clarification on how it should be implemented. This paper reviews evidence of MDT interventions in people with PD and provides expert clinical perspectives for an MDT approach, with a focus on advanced PD and levodopa-carbidopa intestinal gel (carbidopa-levodopa enteral suspension in the USA). The key recommendations are to enable the best possible treatment of people with PD locally by facilitating a close structured collaboration of different health care professionals working in a fixed network structure; to refer people with PD to established MDT centers in a timely manner; to establish regular meetings for the MDT enabling interdisciplinary exchange and learning; to optimize individual treatment and carefully evaluate available treatment options; to ensure treatment decisions are agreed jointly between people with PD, their caregivers, family, and health care professional; and to include specialists outside of neurology from adjuvant medical departments as necessary when implementing advanced therapies.

摘要

帕金森病(PD)治疗指南越来越推荐采用多学科团队(MDT)方法,但目前尚无该方法的护理标准,且指南未对其实施方式作出明确说明。本文回顾了针对PD患者的MDT干预证据,并提供了MDT方法的专家临床观点,重点关注晚期PD和左旋多巴 - 卡比多巴肠凝胶(在美国为卡比多巴 - 左旋多巴肠内混悬液)。关键建议包括:通过促进在固定网络结构中工作的不同医疗保健专业人员进行密切的结构化协作,在当地为PD患者提供尽可能最佳的治疗;及时将PD患者转诊至已建立的MDT中心;为MDT定期召开会议,以促进跨学科交流与学习;优化个体化治疗并仔细评估可用的治疗方案;确保PD患者、其护理人员、家人和医疗保健专业人员共同商定治疗决策;在实施高级疗法时,必要时纳入来自辅助医疗部门的非神经科专家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0f8/5221801/a1f3642cde49/jmdh-10-013Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0f8/5221801/cf00d6e2d258/jmdh-10-013Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0f8/5221801/a1f3642cde49/jmdh-10-013Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0f8/5221801/cf00d6e2d258/jmdh-10-013Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0f8/5221801/a1f3642cde49/jmdh-10-013Fig2.jpg

相似文献

1
The role and structure of the multidisciplinary team in the management of advanced Parkinson's disease with a focus on the use of levodopa-carbidopa intestinal gel.多学科团队在晚期帕金森病管理中的作用和结构,重点关注左旋多巴-卡比多巴肠凝胶的使用
J Multidiscip Healthc. 2017 Jan 4;10:13-27. doi: 10.2147/JMDH.S111369. eCollection 2017.
2
Carbidopa levodopa enteral suspension.卡比多巴左旋多巴肠内悬浮液。
Expert Opin Pharmacother. 2015;16(18):2807-17. doi: 10.1517/14656566.2015.1111336. Epub 2015 Nov 23.
3
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.通过经皮内镜胃造口术放置空肠延长管对晚期帕金森病患者持续空肠内输注左旋多巴-卡比多巴肠凝胶:一项初步研究。
Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2413-7.
4
Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease.左旋多巴/卡比多巴肠内混悬液:治疗晚期帕金森病的综述。
Drugs. 2019 Oct;79(15):1709-1718. doi: 10.1007/s40265-019-01201-1.
5
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.左旋多巴-卡比多巴肠凝胶对晚期帕金森病患者运动障碍的影响。
Mov Disord. 2016 Apr;31(4):530-7. doi: 10.1002/mds.26528. Epub 2016 Jan 28.
6
[Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania].[罗马尼亚特尔古穆列什神经病学诊所经验中晚期帕金森病左旋多巴治疗的特点]
Orv Hetil. 2019 Apr;160(17):662-669. doi: 10.1556/650.2019.31354.
7
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病的长期安全性和疗效。
Mov Disord. 2018 Jul;33(6):928-936. doi: 10.1002/mds.27338. Epub 2018 Mar 23.
8
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.左旋多巴/卡比多巴肠凝胶与晚期帕金森病标准治疗相比的成本效益。
J Med Econ. 2017 Nov;20(11):1207-1215. doi: 10.1080/13696998.2017.1379411. Epub 2017 Sep 21.
9
The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.左旋多巴-卡比多巴肠凝胶输注长期治疗对晚期帕金森病运动并发症的影响:罗马尼亚多中心经验
J Neural Transm (Vienna). 2016 Apr;123(4):407-14. doi: 10.1007/s00702-015-1496-z. Epub 2015 Dec 23.
10
Cost-effectiveness of Levodopa-Carbidopa Intestinal Gel in treating people with Advanced Parkinson's disease.左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病患者的成本效益
Br J Neurosci Nurs. 2023 Aug 2;19(4):140-144. doi: 10.12968/bjnn.2023.19.4.140. Epub 2023 Aug 31.

引用本文的文献

1
Analysis of factors affecting hospitalization costs in Parkinson disease patients: A retrospective study based on 848 cases.帕金森病患者住院费用影响因素分析:一项基于848例病例的回顾性研究
Medicine (Baltimore). 2025 Feb 14;104(7):e41540. doi: 10.1097/MD.0000000000041540.
2
The palliative care needs and experiences of patients with advanced Parkinson's disease: a qualitative scoping review.晚期帕金森病患者的姑息治疗需求与体验:一项定性范围综述
Front Med (Lausanne). 2024 Apr 10;11:1362828. doi: 10.3389/fmed.2024.1362828. eCollection 2024.
3
Home-Based Titration with Duodenal Infusion of Levodopa-Carbidopa Intestinal Gel in People with Parkinson's Disease: An Observational Feasibility Study.

本文引用的文献

1
Towards proactive active living: patients with Parkinson's disease experience of a multidisciplinary intensive rehabilitation treatment.迈向积极的主动生活:帕金森病患者对多学科强化康复治疗的体验
Eur J Phys Rehabil Med. 2017 Feb;53(1):114-124. doi: 10.23736/S1973-9087.16.04213-1. Epub 2016 Jun 1.
2
Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson's disease.多学科强化康复治疗可改善帕金森病患者的睡眠质量。
J Clin Mov Disord. 2015 Apr 2;2:11. doi: 10.1186/s40734-015-0020-9. eCollection 2015.
3
Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
帕金森病患者家庭式十二指肠内输注左旋多巴-卡比多巴肠凝胶滴定:一项观察性可行性研究
Parkinsons Dis. 2024 Apr 8;2024:5522824. doi: 10.1155/2024/5522824. eCollection 2024.
4
The advantages of artificial intelligence-based gait assessment in detecting, predicting, and managing Parkinson's disease.基于人工智能的步态评估在帕金森病检测、预测及管理中的优势。
Front Aging Neurosci. 2023 Jul 12;15:1191378. doi: 10.3389/fnagi.2023.1191378. eCollection 2023.
5
Infusion Therapies in the Treatment of Parkinson's Disease.输注治疗在帕金森病中的应用。
J Parkinsons Dis. 2023;13(5):641-657. doi: 10.3233/JPD-225112.
6
Increasing Use of Telemedicine for Neurological Disorders During the COVID-19 Pandemic: A Mini-Review.2019年冠状病毒病大流行期间远程医疗在神经系统疾病中的应用增加:一项小型综述
J Multidiscip Healthc. 2023 Feb 14;16:411-418. doi: 10.2147/JMDH.S390013. eCollection 2023.
7
A Narrative Review of Specialist Parkinson's Nurses: Evolution, Evidence and Expectation.帕金森病专科护士的叙事综述:演变、证据与期望
Geriatrics (Basel). 2022 Apr 7;7(2):46. doi: 10.3390/geriatrics7020046.
8
Artificial intelligence applications and robotic systems in Parkinson's disease (Review).帕金森病中的人工智能应用与机器人系统(综述)
Exp Ther Med. 2022 Feb;23(2):153. doi: 10.3892/etm.2021.11076. Epub 2021 Dec 17.
9
Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical Issues.将帕金森病的先进疗法推向临床:伦理问题分析。
J Parkinsons Dis. 2021;11(s2):S147-S155. doi: 10.3233/JPD-212639.
10
Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners.左旋多巴-卡比多巴肠凝胶在帕金森病中的应用:美国从业者的见解
Mov Disord Clin Pract. 2018 Jun 27;5(4):383-393. doi: 10.1002/mdc3.12630. eCollection 2018 Jul-Aug.
基于人群的帕金森病发病队列中运动并发症的风险及病程
Parkinsonism Relat Disord. 2016 Jan;22:48-53. doi: 10.1016/j.parkreldis.2015.11.007. Epub 2015 Nov 6.
4
A seat at the table for people with Parkinson's disease.为帕金森病患者争取一席之地。
Lancet Neurol. 2015 Nov;14(11):1077-8. doi: 10.1016/S1474-4422(15)00246-X.
5
Nonpharmacological treatments for patients with Parkinson's disease.帕金森病患者的非药物治疗方法。
Mov Disord. 2015 Sep 15;30(11):1504-20. doi: 10.1002/mds.26363. Epub 2015 Aug 14.
6
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.帕金森病临床相关未解决问题管理中非口服药物治疗方法的集体医生观点:一项国际调查和讨论项目的共识
Parkinsonism Relat Disord. 2015 Oct;21(10):1133-44. doi: 10.1016/j.parkreldis.2015.07.020. Epub 2015 Jul 23.
7
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.阿扑吗啡治疗帕金森病专家共识组报告——临床实践建议
Parkinsonism Relat Disord. 2015 Sep;21(9):1023-30. doi: 10.1016/j.parkreldis.2015.06.012. Epub 2015 Jun 17.
8
In-patient multidisciplinary rehabilitation for Parkinson's disease: A randomized controlled trial.帕金森病住院多学科康复治疗:一项随机对照试验。
Mov Disord. 2015 Jul;30(8):1050-8. doi: 10.1002/mds.26256. Epub 2015 Jun 11.
9
Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials.左旋多巴-卡比多巴肠凝胶的起始治疗与剂量优化:来自3期临床试验的见解
Parkinsonism Relat Disord. 2015 Jul;21(7):742-8. doi: 10.1016/j.parkreldis.2015.04.022. Epub 2015 Apr 28.
10
Support supplied by Parkinson's disease specialist nurses to Parkinson's disease patients and their spouses.帕金森病专科护士为帕金森病患者及其配偶提供的支持。
Appl Nurs Res. 2015 May;28(2):86-91. doi: 10.1016/j.apnr.2014.12.008. Epub 2015 Feb 26.